CHICAGO--(BUSINESS WIRE)--Nucleai, an AI-powered spatial biomarker and diagnostics company, today announced the launch of its deep learning model that automates the normalization of high-plex imaging ...
Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback